Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT00628199
Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability
Sponsor: Stanford University
View on ClinicalTrials.gov
Summary
This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.
Official title: Derivation of Primary Donor Cell Lines for Human Cell Reprogramming
Key Details
Gender
All
Age Range
1 Year - 75 Years
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2007-09
Completion Date
2030-01
Last Updated
2022-08-12
Healthy Volunteers
Yes
Conditions
Interventions
PROCEDURE
Improving the scientific process of human cell reprogramming
Locations (1)
Stanford University School of Medicine
Stanford, California, United States